How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation

The novel oral anticoagulants or direct oral anticoagulants (DOAC) are becoming more common in clinical practice for the prevention of stroke in non-valvular atrial fibrillation (NVAF). The availability of several agents with similar efficacy and safety for stroke prevention in NVAF patients offers...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, Jordan K., McBane, Robert D., Wysokinski, Waldemar E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742513/
https://www.ncbi.nlm.nih.gov/pubmed/26658769
http://dx.doi.org/10.1007/s00277-015-2566-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742513/
https://www.ncbi.nlm.nih.gov/pubmed/26658769
http://dx.doi.org/10.1007/s00277-015-2566-x

Ejemplares similares